Psychiatry & Neurology Doctors in Lakewood, WA Accepting Medicare

15 Psychiatry & Neurology doctors found. Showing 1 - 15

Ms. Ileana Calinoiu, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 8805 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-756-2322    Fax: 253-756-3911

Pietro M Poletti, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 9115 Bridgeport Way Sw Ste 1, Lakewood, WA 98499 Phone: 206-743-4469    Fax: 425-212-1808

Alex Beugelsdijk, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9601 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-582-8900

Dr. Russell D Hicks, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 9330 59th Ave Sw, - Multicare Behavioral Health, Lakewood, WA 98499 Phone: 253-445-8120    Fax: 253-697-8590

Dr. Armando Serna Heredia, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 9601 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-582-8900

Dr. Manuel Francisco Bautista, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9115 Bridgeport Way Sw, Ste 1, Lakewood, WA 98499 Phone: 253-581-6303    Fax: 253-581-3316

John Gregory Zoltani, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 7502 Lakewood Dr W, Suite C-7, Lakewood, WA 98499 Phone: 253-581-8151    Fax: 253-581-8152

Dr. Lanna Mercedes Moore-duncan, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9601 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-582-8900

Muhammad Bilal, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 9601 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-582-8900

Dr. Jon Montgomery Mcclellan, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 8805 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-756-2319    Fax: 253-756-3911

Keiko Howard, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11311 Bridgeport Way Sw, Suite 301 Ms-42-03, Lakewood, WA 98499 Phone: 253-274-7505    Fax: 253-985-2918

Dr. Michael Guy Storck, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 8805 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-756-2397    Fax: 253-756-3911

Mr. Leslie Andrew Sziebert, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9601 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-582-8900    Fax: 253-756-2963

Dr. Lynda Lee Carlisle, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 8805 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-756-2688    Fax: 253-756-3911

Dr. Kris Allen Peterson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 9115 Bridgeport Way Sw Ste 2, Lakewood, WA 98499 Phone: 253-393-9099    Fax: 253-393-9098

News Archive

Clinical trials of personalised vaccines to fight glioblastomas

The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines —produced from healthy and tumour cells from the patient him or herself— and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.

Study reveals radiation therapy advantage for patients with right-sided colorectal tumors

For patients with colorectal cancer that has metastasized to the liver, having a primary tumor on the left side, as opposed to the right side of the colon, is known to be a significant advantage in terms of treatment response.

Onyx announces results from regorafenib Phase 3 trial on GIST

Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

A research team from Spain has prepared a Cochrane systematic review that explores the efficacy, safety, and adherence to fixed-dose combinations (FDCs) of drugs versus single-drug formulations to treat people who are newly diagnosed with tuberculosis (TB).

Researchers are pioneering regenerative medicine techniques that could help millions of Americans heal faster after dental surgeries

More than 10 million Americans undergo surgical tooth extractions every year, and the procedure invariably involves some loss of bone from the tooth socket. This bone loss is problematic for dentists because it can compromise both the functional and esthetic outcomes of treatment involving dentures and bridges. Significant losses of bone also make it difficult for surgeons to properly fit dental implants to the ridge of the jawbone without requiring additional surgical procedures.

Read more Medical News

› Verified 2 days ago